Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.7T | 10.0T | 8.1T | 7.5T |
Cost of revenue | 11.8T | 8.7T | 7.6T | 7.0T |
Gross profit | 942.2B | 1.3T | 528.4B | 555.6B |
Operating expense | ||||
Research & development | — | 16.7B | 9.8B | 10.3B |
Selling general and admin | 108.3B | 36.9B | 26.5B | 22.9B |
Other operating expenses | — | 40.5B | 37.0B | 64.1B |
Operating income | 942.2B | 1.2T | 414.8B | 427.7B |
Non operating interest income | ||||
Income | — | 25.0B | 8.4B | 26.8B |
Expense | — | 377.2B | 344.3B | 369.8B |
Other income expense | — | — | — | — |
Pretax income | 482.5B | 617.7B | 191.6B | 196.3B |
Tax provision | 115.4B | 284.2B | 36.4B | -57.0B |
Net income | 367.2B | 333.5B | 155.2B | 253.3B |
Basic EPS | 4.2K | — | 1.7K | 2.9K |
Diluted EPS | 4.2K | — | 1.6K | 2.7K |
Basic average shares | — | — | 89.2M | 86.6M |
Diluted average shares | — | — | 94.9M | 92.5M |
EBITDA | 942.2B | 1.3T | 1.2T | 958.1B |
Net income from continuing op. | — | 333.5B | 155.2B | 253.3B |
Minority interests | 308M | -1.1B | -104.8M | -427.2M |
Preferred stock dividends | — | — | — | — |